• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种 SARS-CoV-2 IgG 免疫分析比较及抗体反应的时间进程。

Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response.

机构信息

Laboratory Medicine Unit, Ospedale dell'Angelo, Mestre, Italy.

Laboratory Medicine Unit, Ospedale dell'Angelo, Mestre, Italy.

出版信息

Diagn Microbiol Infect Dis. 2021 Apr;99(4):115297. doi: 10.1016/j.diagmicrobio.2020.115297. Epub 2020 Dec 24.

DOI:10.1016/j.diagmicrobio.2020.115297
PMID:33388574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836402/
Abstract

INTRODUCTION

The persistence of circulating antibodies to SARS-CoV-2 infection is not yet well known. We compare the results of 2 automated systems for the determination of IgG against SARS CoV-2 and assess the time-course of the IgG response.

METHODS

IgG were measured in 103 specimens of 55 patients with COVID-19 (time from the symptoms' onset: 3-187 days) using the automated tests "Abbott SARS-COV-2 IgG" and "MAGLUMI 2019-nCoV IgG".

RESULTS

The 2 methods had a concordance of 90.3%, but the quantitative correlation, although significant, showed dispersed results. All the specimens resulted positive after 17 days. However, the median concentrations of IgG rapidly increased up to 20 days and decreased for Maglumi IgG while Abbott IgG showed a constant trend up to 85 days, and then slowly declined.

CONCLUSIONS

The titer of IgG against SARS-CoV-2 may significantly and rapidly decrease, but with a very different time-course depending on the method used for the determination.

摘要

简介

目前尚不清楚 SARS-CoV-2 感染后循环抗体的持续时间。我们比较了两种用于检测 SARS-CoV-2 抗体 IgG 的自动化系统的结果,并评估了 IgG 反应的时间过程。

方法

使用自动化检测方法“雅培 SARS-CoV-2 IgG”和“MAGLUMI 2019-nCoV IgG”,对 55 例 COVID-19 患者的 103 份标本(从症状出现开始的时间:3-187 天)进行 IgG 测量。

结果

两种方法的一致性为 90.3%,但定量相关性虽然显著,但结果分散。所有标本在 17 天后均呈阳性。然而,IgG 的中位数浓度迅速增加至 20 天,而 Maglumi IgG 则下降,Abbott IgG 则呈持续趋势直至 85 天,然后缓慢下降。

结论

SARS-CoV-2 抗体 IgG 的滴度可能会显著且快速下降,但取决于用于检测的方法,其时间过程则非常不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/4c1068e56211/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/ab7226a01cbc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/09e8f09317c0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/6ddc37919db7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/4c1068e56211/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/ab7226a01cbc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/09e8f09317c0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/6ddc37919db7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa77/7836402/4c1068e56211/gr4_lrg.jpg

相似文献

1
Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response.两种 SARS-CoV-2 IgG 免疫分析比较及抗体反应的时间进程。
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115297. doi: 10.1016/j.diagmicrobio.2020.115297. Epub 2020 Dec 24.
2
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.使用商业酶联免疫吸附试验和化学发光免疫分析方法推断住院 COVID-19 患者血清中 SARS-CoV-2 刺突结合中和抗体效价。
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):485-494. doi: 10.1007/s10096-020-04128-8. Epub 2021 Jan 6.
3
Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.利用定性和定量免疫诊断检测监测重症 COVID-19 患者的特异性 IgM 和 IgG 产生:一项回顾性队列研究。
Front Immunol. 2021 Sep 3;12:705441. doi: 10.3389/fimmu.2021.705441. eCollection 2021.
4
Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.三种自动化定量免疫分析方法的性能评估及其与新型冠状病毒病患者和大流行前对照者替代病毒中和试验的相关性。
J Clin Lab Anal. 2021 Sep;35(9):e23921. doi: 10.1002/jcla.23921. Epub 2021 Aug 8.
5
Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.抗 SARS-CoV-2 IgM 可提高疾病早期的临床灵敏度。
Clin Biochem. 2021 Apr;90:1-7. doi: 10.1016/j.clinbiochem.2021.01.003. Epub 2021 Jan 19.
6
Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays.四种基于实验室的 SARS-CoV-2 IgG 抗体免疫分析评估。
Diagn Microbiol Infect Dis. 2021 May;100(1):115313. doi: 10.1016/j.diagmicrobio.2021.115313. Epub 2021 Jan 19.
7
An original multiplex method to assess five different SARS-CoV-2 antibodies.一种评估五种不同 SARS-CoV-2 抗体的原始多重方法。
Clin Chem Lab Med. 2020 Dec 21;59(5):971-978. doi: 10.1515/cclm-2020-1652. Print 2021 Apr 27.
8
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).评估三种免疫测定法(Euroimmun 和 Abbott 的两种自动化免疫测定法以及 NG Biotech 的一种快速侧向流动免疫测定法)用于诊断 COVID-19 的 SARS-CoV-2 血清学检测。
J Clin Virol. 2020 Aug;129:104511. doi: 10.1016/j.jcv.2020.104511. Epub 2020 Jun 15.
9
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.美国两个城市住院患者中新冠病毒 IgM 和 IgG 血清转化情况的比较。
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115300. doi: 10.1016/j.diagmicrobio.2020.115300. Epub 2020 Dec 24.
10
SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.SARS-CoV-2 抗体检测在医护人员中的应用:三种市售抗体检测试剂盒的临床性能比较。
Microbiol Spectr. 2021 Oct 31;9(2):e0039121. doi: 10.1128/Spectrum.00391-21. Epub 2021 Sep 29.

引用本文的文献

1
Antibodies against SARS-CoV-2 Time Course in Patients and Vaccinated Subjects: An Evaluation of the Harmonization of Two Different Methods.SARS-CoV-2抗体在患者和接种疫苗者中的时间进程:两种不同方法的一致性评估。
Diagnostics (Basel). 2021 Sep 18;11(9):1709. doi: 10.3390/diagnostics11091709.
2
Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test.使用三种全自动免疫测定法和替代病毒中和试验检测COVID-19患者中SARS-CoV-2刺突抗体的定量反应
Diagnostics (Basel). 2021 Aug 19;11(8):1496. doi: 10.3390/diagnostics11081496.
3

本文引用的文献

1
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.用于鉴定 SARS-CoV-2 感染血清学特征的多重分析:基于抗体的诊断和机器学习研究。
Lancet Microbe. 2021 Feb;2(2):e60-e69. doi: 10.1016/S2666-5247(20)30197-X. Epub 2020 Dec 21.
2
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity.五种用于检测 SARS-CoV-2 抗体的免疫分析方法的分析和临床性能与中和活性的比较。
EBioMedicine. 2020 Dec;62:103101. doi: 10.1016/j.ebiom.2020.103101. Epub 2020 Nov 4.
3
Persistence of humoral response upon SARS-CoV-2 infection.
SARS-CoV-2 感染后体液免疫应答的持久性。
Rev Med Virol. 2022 Mar;32(2):e2272. doi: 10.1002/rmv.2272. Epub 2021 Jun 30.
4
Evaluation of the performance of SARS--CoV--2 antibody assays for a longitudinal population-based study of COVID--19 spread in St. Petersburg, Russia.评估 SARS-CoV-2 抗体检测在俄罗斯圣彼得堡进行的 COVID-19 传播纵向基于人群研究中的表现。
J Med Virol. 2021 Oct;93(10):5846-5852. doi: 10.1002/jmv.27126. Epub 2021 Jun 12.
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
轻度新冠病毒感染中抗新冠病毒-2抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1695-1696. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
4
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻症新冠患者体内抗SARS-CoV-2抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
5
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠患者体内抗新冠病毒抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1694-1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
6
Humoral Immune Response to SARS-CoV-2 in Iceland.冰岛人针对 SARS-CoV-2 的体液免疫反应。
N Engl J Med. 2020 Oct 29;383(18):1724-1734. doi: 10.1056/NEJMoa2026116. Epub 2020 Sep 1.
7
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.监测 SARS-CoV-2 感染后的抗体反应:4 种自动化免疫分析的诊断效率。
Diagn Microbiol Infect Dis. 2020 Nov;98(3):115140. doi: 10.1016/j.diagmicrobio.2020.115140. Epub 2020 Jul 12.
8
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
9
The early antibody response to SARS-Cov-2 infection.对SARS-CoV-2感染的早期抗体反应。
Clin Chem Lab Med. 2020 Sep 25;58(10):e201-e203. doi: 10.1515/cclm-2020-0617.
10
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).评估三种免疫测定法(Euroimmun 和 Abbott 的两种自动化免疫测定法以及 NG Biotech 的一种快速侧向流动免疫测定法)用于诊断 COVID-19 的 SARS-CoV-2 血清学检测。
J Clin Virol. 2020 Aug;129:104511. doi: 10.1016/j.jcv.2020.104511. Epub 2020 Jun 15.